CD8A and osteosarcoma: Research by Schell et al. in an SV40 large T antigen-induced osteosarcoma model found CTLs exhibited reduced responsiveness to particular epitopes, with a substantial reduction in specific CD8+ T cells, denoting tumor progression is associated with a decrease in immune cell efficacy, impacting tumor immune surveillance and response capabilities (Schell et al., 2000).